Letters16 July 2019
    Author, Article and Disclosure Information

    Background: Plasmapheresis is necessary to treat some cases of severe hypertriglyceridemia.

    Objective: To describe successful treatment of severe hypertriglyceridemia in a patient for whom plasmapheresis was not possible.

    Case Report: A 39-year-old man came to the emergency department with nausea, vomiting, malaise, headache, and slowly deteriorating alertness. He had diabetes mellitus of an unknown type and a history of cholelithiasis and cholecystitis. He had been prescribed daily doses of sitagliptin, 100 mg; dapagliflozin, 10 mg; and pantoprazole, 40 mg, but he was taking these drugs intermittently. Two days earlier, he saw an outpatient physician for nausea, vomiting, unwanted weight loss, ...

    References

    • 1. Lek M Karczewski KJ Minikel EV Samocha KE Banks E Fennell T et alExome Aggregation ConsortiumAnalysis of protein-coding genetic variation in 60,706 humans. Nature2016;536:285-91. [PMID: 27535533] doi:10.1038/nature19057 CrossrefMedlineGoogle Scholar
    • 2. Ewald N Kloer HU Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis. Clin Res Cardiol Suppl2012;7:31-5. [PMID: 22528130] CrossrefMedlineGoogle Scholar
    • 3. Erondu N Desai M Ways K Meininger G Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program. Diabetes Care2015;38:1680-6. [PMID: 26203064] doi:10.2337/dc15-1251 CrossrefMedlineGoogle Scholar
    • 4. Peters AL Buschur EO Buse JB Cohan P Diner JC Hirsch IB Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care2015;38:1687-93. [PMID: 26078479] doi:10.2337/dc15-0843 CrossrefMedlineGoogle Scholar